_id
690db166ccc777a4e85d0bee
Ticker
ASBP
Name
Aspire BioPharma, Inc.
Exchange
NASDAQ
Address
23150 Fashion Drive, Estero, FL, United States, 33928
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://aspirebiolabs.com
Description
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers Instaprin, a sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, including a melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.
Last Close
2.2
Volume
1266738
Current Price
2.2
Change
-0.01
Last Updated
2026-01-20T15:43:39.204Z
Image
data:image/webp;base64,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
Ipo Date
2022-04-11T00:00:00.000Z
Market Cap
8840000
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.997
Sentiment Sources
1
Current Quarter
2025-09-30
Revenue
1941
Cost Of Revenue
1057
Gross Profit
884
Operating Expenses
1146381
Operating Income
-1145497
Interest Expense
1480058
Pretax Income
-1850493
Net Income
-1850493
Eps
-0.00934102350746487
Dividends Per Share
-
Shares Outstanding
4000000
Income Tax Expense
-
EBITDA
2021209
Operating Margin
-59015.816589386915
Total Other Income Expense Net
-704996
Cash
1948271
Short Term Investments
-
Receivables
-
Inventories
35437
Total Current Assets
2403129
Property Plant Equipment
-
Total Assets
2403129
Payables
1060889
Short Term Debt
1384778
Long Term Debt
-
Total Liabilities
13870407
Equity
-11467278
Bs_currency_symbol
USD
Depreciation
2021209
Change In Working Capital
318361
Cash From Operations
-1103809
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
2845847
Net Change In Cash
1742038
Cf_currency_symbol
USD
PE
-
PB
-38.00627629329297
ROE
16.13716001303884
ROA
-77.00348171071964
FCF
-1103809
Fcf Percent
-568.6805770221536
Piotroski FScore
1
Health Score
28
Deep Value Investing Score
1
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
1.5
Growth Investing Score
1
Momentum Investing Score
2
Net Net Investing Score
0.5
Quality Investing Score
1.5
Value Investing Score
2
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
1941
Quarters > 0 > income Statement > cost Of Revenue
1057
Quarters > 0 > income Statement > gross Profit
884
Quarters > 0 > income Statement > operating Expenses
1146381
Quarters > 0 > income Statement > operating Income
-1145497
Quarters > 0 > income Statement > interest Expense
1480058
Quarters > 0 > income Statement > pretax Income
-1850493
Quarters > 0 > income Statement > net Income
-1850493
Quarters > 0 > income Statement > eps
-0.00934102350746487
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
198103880
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
2021209
Quarters > 0 > income Statement > operating Margin
-59015.816589386915
Quarters > 0 > income Statement > total Other Income Expense Net
-704996
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
1948271
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
35437
Quarters > 0 > balance Sheet > total Current Assets
2403129
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
2403129
Quarters > 0 > balance Sheet > payables
1060889
Quarters > 0 > balance Sheet > short Term Debt
1384778
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
13870407
Quarters > 0 > balance Sheet > equity
-11467278
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-1850821
Quarters > 0 > cash Flow > depreciation
2021209
Quarters > 0 > cash Flow > change In Working Capital
318361
Quarters > 0 > cash Flow > cash From Operations
-1103809
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
2845847
Quarters > 0 > cash Flow > net Change In Cash
1742038
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.00934102350746487
Quarters > 0 > ratios > PB
-38.00627629329297
Quarters > 0 > ratios > ROE
16.13716001303884
Quarters > 0 > ratios > ROA
-77.00348171071964
Quarters > 0 > ratios > FCF
-1103809
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-568.6805770221536
Quarters > 0 > health Score
28
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
799890
Quarters > 1 > income Statement > operating Income
-799890
Quarters > 1 > income Statement > interest Expense
527893
Quarters > 1 > income Statement > pretax Income
-1981293
Quarters > 1 > income Statement > net Income
-1981293
Quarters > 1 > income Statement > eps
-0.010040269258746695
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
197334648
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-1453400
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-1181403
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
206233
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
989422
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
989422
Quarters > 1 > balance Sheet > payables
1351639
Quarters > 1 > balance Sheet > short Term Debt
1830571
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
10606207
Quarters > 1 > balance Sheet > equity
-9616785
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-1981293
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-260034000
Quarters > 1 > cash Flow > cash From Operations
-1140310
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
0
Quarters > 1 > cash Flow > net Change In Cash
-1140310
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.010040269258746695
Quarters > 1 > ratios > PB
-45.143592749551956
Quarters > 1 > ratios > ROE
20.602446659668487
Quarters > 1 > ratios > ROA
-200.24751824802763
Quarters > 1 > ratios > FCF
-1140310
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
39
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
15556000
Quarters > 2 > income Statement > operating Income
-1425230
Quarters > 2 > income Statement > interest Expense
290000
Quarters > 2 > income Statement > pretax Income
-15941000
Quarters > 2 > income Statement > net Income
-15941000
Quarters > 2 > income Statement > eps
-0.10517946687780418
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
151560000
Quarters > 2 > income Statement > income Tax Expense
-1013
Quarters > 2 > income Statement > EBITDA
-15651397
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-14516098
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
1346543
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
36503
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
1965514
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
1965514
Quarters > 2 > balance Sheet > payables
1432025
Quarters > 2 > balance Sheet > short Term Debt
1710560
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
8918256
Quarters > 2 > balance Sheet > equity
-6952742
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-15941000
Quarters > 2 > cash Flow > depreciation
-2630000
Quarters > 2 > cash Flow > change In Working Capital
-326298
Quarters > 2 > cash Flow > cash From Operations
-1751528
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
3094438
Quarters > 2 > cash Flow > net Change In Cash
1342910
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.10517946687780418
Quarters > 2 > ratios > PB
-47.95690678584076
Quarters > 2 > ratios > ROE
229.27644949287634
Quarters > 2 > ratios > ROA
-811.0346708291063
Quarters > 2 > ratios > FCF
-1751528
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
39
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
2518312
Quarters > 3 > income Statement > operating Income
-2518312
Quarters > 3 > income Statement > interest Expense
891624
Quarters > 3 > income Statement > pretax Income
-11967113
Quarters > 3 > income Statement > net Income
-11966100
Quarters > 3 > income Statement > eps
-0.25120088280229014
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
47635581
Quarters > 3 > income Statement > income Tax Expense
-1013
Quarters > 3 > income Statement > EBITDA
-11075489
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-9448801
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
3633
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
36503
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
147989
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
147989
Quarters > 3 > balance Sheet > payables
310219
Quarters > 3 > balance Sheet > short Term Debt
1266832
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1688077
Quarters > 3 > balance Sheet > equity
-1540088
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-8931094
Quarters > 3 > cash Flow > depreciation
0
Quarters > 3 > cash Flow > change In Working Capital
1218069
Quarters > 3 > cash Flow > cash From Operations
479569
Quarters > 3 > cash Flow > capital Expenditures
4
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-492477
Quarters > 3 > cash Flow > net Change In Cash
-12908
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.25120088280229014
Quarters > 3 > ratios > PB
-68.04694160333696
Quarters > 3 > ratios > ROE
776.9750819433694
Quarters > 3 > ratios > ROA
-8085.803674597436
Quarters > 3 > ratios > FCF
479565
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
40
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
3089000
Annuals > 0 > income Statement > operating Income
-3088671
Annuals > 0 > income Statement > interest Expense
892000
Annuals > 0 > income Statement > pretax Income
-12537000
Annuals > 0 > income Statement > net Income
-12537000
Annuals > 0 > income Statement > eps
-0.38018558951965065
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
32976000
Annuals > 0 > income Statement > income Tax Expense
1013
Annuals > 0 > income Statement > EBITDA
-11645848
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-9448801
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
3633
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
36503
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
147989
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
147989
Annuals > 0 > balance Sheet > payables
310219
Annuals > 0 > balance Sheet > short Term Debt
1266832
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1688077
Annuals > 0 > balance Sheet > equity
-1540088
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-1309872
Annuals > 0 > cash Flow > depreciation
0
Annuals > 0 > cash Flow > change In Working Capital
1033991
Annuals > 0 > cash Flow > cash From Operations
-265186
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
13781323
Annuals > 0 > cash Flow > cash From Financing
257645
Annuals > 0 > cash Flow > net Change In Cash
-7541
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.38018558951965065
Annuals > 0 > ratios > PB
-47.105879664019206
Annuals > 0 > ratios > ROE
814.0443922684938
Annuals > 0 > ratios > ROA
-8471.575590077642
Annuals > 0 > ratios > FCF
-265186
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
0
Annuals > 1 > income Statement > gross Profit
0
Annuals > 1 > income Statement > operating Expenses
1340000
Annuals > 1 > income Statement > operating Income
-1340000
Annuals > 1 > income Statement > interest Expense
8966
Annuals > 1 > income Statement > pretax Income
4464000
Annuals > 1 > income Statement > net Income
4464000
Annuals > 1 > income Statement > eps
0.058188643829188175
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
76716000
Annuals > 1 > income Statement > income Tax Expense
481
Annuals > 1 > income Statement > EBITDA
5804000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
5804000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
11174
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
81223
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
19982392
Annuals > 1 > balance Sheet > payables
152005
Annuals > 1 > balance Sheet > short Term Debt
12384
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
403328
Annuals > 1 > balance Sheet > equity
19579064
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
4464079
Annuals > 1 > cash Flow > depreciation
0
Annuals > 1 > cash Flow > change In Working Capital
687061
Annuals > 1 > cash Flow > cash From Operations
-653107
Annuals > 1 > cash Flow > capital Expenditures
3
Annuals > 1 > cash Flow > cash From Investing
284916127
Annuals > 1 > cash Flow > cash From Financing
-284760279
Annuals > 1 > cash Flow > net Change In Cash
-497259
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
0.058188643829188175
Annuals > 1 > ratios > PB
8.620187359314011
Annuals > 1 > ratios > ROE
22.79986418145423
Annuals > 1 > ratios > ROA
22.339667843569476
Annuals > 1 > ratios > FCF
-653110
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
66
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
0
Annuals > 2 > income Statement > gross Profit
0
Annuals > 2 > income Statement > operating Expenses
976345
Annuals > 2 > income Statement > operating Income
-976345
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
3340000
Annuals > 2 > income Statement > net Income
3340000
Annuals > 2 > income Statement > eps
0.026353995707612675
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
126736000
Annuals > 2 > income Statement > income Tax Expense
626
Annuals > 2 > income Statement > EBITDA
3340238
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
4317000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
497259
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
1097752
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
300182005
Annuals > 2 > balance Sheet > payables
180634
Annuals > 2 > balance Sheet > short Term Debt
27967
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
11115823
Annuals > 2 > balance Sheet > equity
289066182
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
3340238
Annuals > 2 > cash Flow > depreciation
0
Annuals > 2 > cash Flow > change In Working Capital
-432441
Annuals > 2 > cash Flow > cash From Operations
-1408786
Annuals > 2 > cash Flow > capital Expenditures
4
Annuals > 2 > cash Flow > cash From Investing
-294687500
Annuals > 2 > cash Flow > cash From Financing
296593545
Annuals > 2 > cash Flow > net Change In Cash
497259
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
0.026353995707612675
Annuals > 2 > ratios > PB
0.9645514327234586
Annuals > 2 > ratios > ROE
1.1554447417166218
Annuals > 2 > ratios > ROA
1.1126583020857628
Annuals > 2 > ratios > FCF
-1408790
Annuals > 2 > ratios > Piotroski FScore
2
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
50
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
-
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
25475
Annuals > 3 > income Statement > operating Income
-25480
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-25475
Annuals > 3 > income Statement > net Income
-25475
Annuals > 3 > income Statement > eps
-0.001019
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
25000000
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-25480
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
5
Annuals > 3 > income Statement > currency_symbol
-
Annuals > 3 > balance Sheet > cash
-
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
293221
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
293221
Annuals > 3 > balance Sheet > payables
273
Annuals > 3 > balance Sheet > short Term Debt
238596
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
293696
Annuals > 3 > balance Sheet > equity
-475
Annuals > 3 > balance Sheet > currency_symbol
-
Annuals > 3 > cash Flow > net Income
-27.79
Annuals > 3 > cash Flow > depreciation
27791
Annuals > 3 > cash Flow > change In Working Capital
-232
Annuals > 3 > cash Flow > cash From Operations
-260
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
260.29
Annuals > 3 > cash Flow > net Change In Cash
-
Annuals > 3 > cash Flow > currency_symbol
-
Annuals > 3 > ratios > PE
-0.001019
Annuals > 3 > ratios > PB
-115789.47368421053
Annuals > 3 > ratios > ROE
5363.157894736842
Annuals > 3 > ratios > ROA
-8.687986194713202
Annuals > 3 > ratios > FCF
-260
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
39
Valuation > metrics > PE
-0.00934102350746487
Valuation > metrics > PB
-38.00627629329297
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
16.13716001303884
Profitability > metrics > ROA
-77.00348171071964
Profitability > metrics > Net Margin
-953.370942812983
Profitability > final Score
32
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-0.7739541288246812
Risk > final Score
27
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.9826067898859493
Liquidity > metrics > Quick Ratio
0.9681170821702219
Liquidity > final Score
58
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
55
Prev Profitabilities > 1
55
Prev Profitabilities > 2
55
Prev Risks > 0
24
Prev Risks > 1
10
Prev Risks > 2
19
Prev Liquidities > 0
26
Prev Liquidities > 1
41
Prev Liquidities > 2
15
Updated At
2026-01-20T21:25:06.720Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-09-30
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.0374
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-13
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.04
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-14
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.42
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-01-08
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-1.1502
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-09-30
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.0692
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-06-30
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-0.0711
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-03-31
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
-0.2744
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2023-12-31
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
-0.0168
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-09-30
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
-0.0077
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-06-30
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
0.0571
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-11
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
-
Earnings History > 10 > eps Actual
0.08
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-21
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
-
Earnings History > 11 > eps Actual
0.06
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-10
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
-
Earnings History > 12 > eps Actual
0.03
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-11
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
-
Earnings History > 13 > eps Actual
0.0034
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-16
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
-
Earnings History > 14 > eps Actual
0
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-09-30
Earnings History > 15 > report Date
2021-12-30
Earnings History > 15 > date
2021-09-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
-
Earnings History > 15 > eps Actual
0
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers Instaprin, a sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, including a melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ABUZZ BOMB caffeine gets sleek new look and direct-to-consumer website Stock Titan
Read more →Aspire Biopharma's Unveils Bold New Era for BUZZ BOMB(TM) Caffeine with Dynamic Website and Packaging Redesign Chartmill
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Medium
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Aspire BioPharma, Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.0374
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.